Waters Corp (WAT): Capital Expenditures
$112.75M
Year ended 2025-12-31
$150.75M
Trailing 12 months to 2026-07-04
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $112.75M | -20.9% | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | $142.48M | -11.3% | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | $160.63M | n/a | 2026-02-23, From 2023-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Waters Corp (WAT) | 2025-12-31 | $112.75M | -20.9% |
| Bruker Corp (BRKR) | 2025-12-31 | $90.80M | -21.2% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $73.52M | -15.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $157.60M | -4.8% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $107.12M | +3.1% |
| Illumina, Inc. (ILMN) | 2025-12-28 | $148.00M | +15.6% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $128.80M | -13.4% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $407.00M | +7.7% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $5.93M | -52.1% |
Compare WAT, BRKR, RVTY, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗